Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
i-PRF vs Tranexamic Acid for Facial Melasma
NCT07540702Recruiting
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Feb 2026
- Primary completion
- Aug 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Randomised, double-blind trial of platelet-rich fibrin cream (Poznan University of Medical Sciences) in melasma (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Modified Melasma Area and Severity Index at Day 90. Started Feb 2026; status: recruiting.
02
Drugs
platelet-rich fibrin cream (Poznan University of Medical Sciences)
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07540702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07540702.